Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Samplix provides commercial-stage microfluidic droplet-based platforms for high-resolution single-cell and molecular analyses. Their Xdrop® system enables PCR-free target enrichment of DNA/RNA from complex samples at single-molecule resolution. The technology supports applications including gene therapy validation, detection of off-target genome editing events, rare variant discovery in genomics studies, enzyme engineering screens, immunotherapy cell function assays (e.g., CAR-T), among others. The products are used by academic labs as well as biopharma R&D groups worldwide. No clinical results—products are for research use only.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Samplix.